Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PI3Kδ inhibitors(Phosphatidylinositol 3 kinase delta inhibitors), Vps34 inhibitors(phosphatidylinositol 3-kinase catalytic subunit type 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H24ClN5O3S2 |
InChIKeyYCVQOWKBUVDTOG-UHFFFAOYSA-N |
CAS Registry1807551-44-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 18 Jul 2016 |